deforolimus

Related by string. Deforolimus * * oral deforolimus . commercialize deforolimus ARIAD . candidate deforolimus . commercialize deforolimus *

Related by context. All words. (Click for frequent words.) 75 alvespimycin 74 elotuzumab 73 enzastaurin 73 Panzem R NCD 72 Phase Ib II 72 SUCCEED trial 72 forodesine 72 L BLP# 72 JAK inhibitor 71 IMA# 71 oral deforolimus 71 Phase 1b trial 71 oral ridaforolimus 71 ridaforolimus 71 MGCD# [001] 71 INCB# [001] 71 HGS# 71 DPX Survivac 71 phase IIa clinical 71 pertuzumab 71 PSMA ADC 71 Phase IIb clinical trials 71 CR# vcMMAE 70 Phase #b/#a clinical 70 Troxatyl 70 Phase Ib study 70 metaglidasen 70 Azedra 70 evaluating tivozanib 70 Nanobody 70 registrational 70 BRAF inhibitor 70 eniluracil 70 confirmatory Phase III 70 docetaxel Taxotere R 70 JAK2 inhibitor 70 Onconase 70 evaluating satraplatin 70 PI3K/Akt pathway inhibitor 70 vosaroxin 70 Phase #b/#a 70 Phase IIIb clinical 70 regorafenib 70 vidofludimus 70 Allovectin 7 70 Genz # 69 phase IIb trial 69 Phase IIb trials 69 PEG SN# 69 phase IIb clinical 69 lintuzumab 69 Phase Ib 69 PXD# 69 paclitaxel Taxol ® 69 Trofex 69 AP# [003] 69 otelixizumab 69 investigational humanized monoclonal antibody 69 huC# DM4 69 neratinib 69 IMC #B 69 acyclovir Lauriad R 69 entinostat 69 sunitinib malate 69 Omacetaxine 69 Panzem R 69 HGS ETR1 69 Tykerb lapatinib 69 multicenter Phase II 69 BrachySil TM 69 HuLuc# 69 ganetespib 69 Archexin 69 Phase Ib clinical 68 rALLy clinical trial 68 sapacitabine 68 axitinib 68 Adnectin 68 OvaRex R 68 AEG# 68 atacicept 68 MNTX 68 BRIM2 68 EndoTAGTM 1 68 GRN# 68 Urocidin 68 obatoclax 68 Personalized Immunotherapy 68 oral prodrug 68 cetuximab Erbitux 68 AEGR 68 oral picoplatin 68 Pertuzumab 68 ASONEP 68 IL# PE#QQR 68 TOCOSOL Paclitaxel 68 BAY #-# 68 incyclinide 68 CCR9 antagonist 68 OMP #M# 68 PDE4 inhibitor 68 Xcytrin R 68 Abiraterone acetate 68 cediranib 68 HepeX B 68 bicifadine 68 lorvotuzumab mertansine 68 Pimavanserin 68 Solazed 68 Vectibix panitumumab 68 therapeutic monoclonal antibody 68 tubulin inhibitor 68 midstage clinical 68 reslizumab 68 Insegia 68 tolevamer 68 compound INCB# 68 YONDELIS 68 Phase 1b 68 FOLOTYN ® 68 Nexavar ® 68 tanespimycin 68 THALOMID 68 MGd 68 Aflibercept 68 MEK inhibitors 68 EndoTAG TM -1 68 DU #b 68 Phase IIa trials 68 seliciclib CYC# 68 TRAIL receptor antibodies 68 SinuNase ™ 68 Allovectin 7 ® 67 romidepsin 67 FOLFOX6 chemotherapy regimen 67 mertansine 67 Quinamed 67 cathepsin K inhibitor 67 ofatumumab 67 Exherin TM 67 anti angiogenic therapy 67 Bezielle 67 ixabepilone 67 HGS ETR2 67 Symadex 67 SAR# [004] 67 thalidomide Thalomid 67 oral salmon calcitonin 67 alemtuzumab Campath 67 Evoltra ® 67 Tarvacin TM 67 PDE# inhibitors 67 selective androgen receptor modulator 67 R sorafenib tablets 67 OncoVEX 67 Ixempra 67 OXi# 67 PrevOnco ™ 67 including eniluracil ADH 67 PRT# 67 IAP inhibitors 67 galiximab 67 candidate deforolimus 67 ThermoDox R 67 Tarceva TM 67 Urocortin 2 67 AzaSite Plus 67 ularitide 67 novel oral anticoagulant 67 Xanafide 67 talactoferrin 67 registrational trial 67 evaluating T DM1 67 oral taxane 67 Viprinex 67 IMC A# 67 metastatic sarcomas 67 Allovectin 7 R 67 virus HCV protease inhibitor 67 PLK1 SNALP 67 preclinically 67 nalbuphine ER 67 GEM OS2 67 atrasentan 67 OMAPRO 67 HCV protease inhibitor 67 brentuximab vedotin SGN 67 ELACYT 67 fostamatinib 67 ALN PCS 67 Onco TCS 67 YONDELIS R 67 Panzem ® 67 dose escalation Phase 67 GMX# 67 volociximab 67 lomitapide 67 Revlimid lenalidomide 67 Velcade bortezomib 67 IRX 2 67 initiated Phase Ib 67 eprotirome 67 PHX# 67 relapsed multiple myeloma 67 glucokinase activator 67 Clolar ® 67 talabostat 67 Fodosine 67 apricitabine ATC 67 Chemophase 67 Cloretazine 67 PSN# [002] 67 GW# [003] 67 LymphoStat B TM 66 OHR/AVR# 66 torezolid phosphate 66 lumiliximab 66 immatics 66 ONCONASE R 66 Deforolimus 66 THR beta agonist 66 BCX# 66 leading oral taxane 66 sapacitabine CYC# 66 CA4P 66 PTK ZK 66 HER2 positive metastatic breast 66 Aurora kinase inhibitor 66 investigational protease inhibitor 66 motesanib 66 Amrubicin 66 Tovaxin TM 66 Zybrestat 66 CRLX# 66 Mipomersen 66 pharmacokinetic PK study 66 Imprime PGG 66 ulimorelin 66 PTK# 66 RELOVAIR ™ 66 antibody MAb 66 investigational compounds 66 radiation sensitizer 66 GLPG# 66 octreotide implant 66 Bicifadine 66 TELINTRA 66 Cloretazine ® 66 Phase #/#a trial 66 Amplimexon 66 pradefovir 66 trastuzumab emtansine T DM1 66 dacetuzumab 66 ocrelizumab 66 Cloretazine R VNP#M 66 Asentar 66 Aplidin 66 angiogenesis inhibitor 66 RhuDex ® 66 Neuradiab 66 IIa trial 66 Phase #/#a 66 zanolimumab 66 FOLOTYN 66 CoFactor 66 Sulonex TM 66 targeted radiotherapeutic 66 GRN#L 66 isoform selective 66 evaluating Nexavar 66 BRIM3 66 sorafenib Nexavar 66 Phase 1a clinical 66 PF # [002] 66 glufosfamide 66 LHRH antagonists 66 initiate Phase 1b 66 HuMax TAC 66 receptor tyrosine kinase inhibitor 66 depsipeptide 66 Phase III metastatic melanoma 66 cannabinor 66 trastuzumab Herceptin R 66 anticancer compound 66 vemurafenib 66 PNP inhibitor 66 DOS# 66 bevacizumab Avastin ® 66 Vascular Wrap TM 66 Reverset 66 muraglitazar 66 trodusquemine 66 trastuzumab DM1 T DM1 66 sunitinib Sutent 66 Erbitux cetuximab 66 NP2 Enkephalin 66 orally administered inhibitor 66 SNT MC# 66 PEG Interferon lambda 66 Carfilzomib 66 Targretin 66 Icatibant 66 Omnitarg 66 HuMax EGFr 66 TACI Ig 66 Dacogen injection 66 phase IIb 66 cancer immunotherapies 66 Kosan dependence 66 Xelox 66 Phase 2b study 66 telomerase inhibitor drug 66 NGX# 66 ATL# [001] 66 pralatrexate 66 XmAb# 66 Exelixis compounds 66 huN# DM1 66 celgosivir 66 LymphoStat B belimumab 66 imetelstat 66 custirsen 66 AMPK activators 66 Factor VIIa 66 vorinostat 66 Ceflatonin 66 placebo controlled clinical 66 OMP #R# 66 registrational studies 66 opioid induced bowel dysfunction 66 ASG 5ME 66 ZK EPO 66 MOZOBIL 66 corticosteroid dexamethasone 66 Ridaforolimus 66 RGB # 66 Elotuzumab 66 ZOLINZA 66 Tyrima 66 Phase IIb III 66 bendamustine 66 Civacir 66 TG# [003] 66 Myocet 65 OvaRex ® MAb 65 EOquin TM 65 TroVax ® 65 ENMD # 65 ProMune 65 Phase 2a trial 65 StemEx 65 Annamycin 65 ospemifene 65 AERx iDMS 65 Genentech Roche 65 MAA submission 65 ARIKACE ™ 65 pomalidomide 65 TBC# 65 ISTODAX 65 hypoxia activated prodrug 65 lintuzumab SGN 65 NPC 1C 65 Potelligent Technology 65 MEND CABG II 65 amrubicin 65 docetaxel Taxotere ® 65 Proellex TM 65 EndoTAG TM 65 Marqibo TM 65 Vitaxin 65 ponatinib 65 tezampanel NGX# 65 gefitinib Iressa 65 Phase 2b clinical trials 65 liposomal formulation 65 CRMD# 65 tezampanel 65 novel histone deacetylase 65 midstage trials 65 Dr. Fahar Merchant 65 clevidipine 65 HIV integrase inhibitor 65 Trastuzumab DM1 65 HepeX B TM 65 CytoFabTM 65 Panzem 65 bardoxolone 65 BCR ABL inhibitor 65 multicenter Phase 65 Initiates Phase III 65 nucleotide analog 65 Fludara ® 65 CBLC# 65 MEK inhibitor 65 initiated Phase 1b 65 LEUKINE 65 Syncria 65 Ceflatonin R 65 TOCOSOL 65 progressive metastatic prostate 65 UVIDEM 65 confirmatory clinical 65 omacetaxine mepesuccinate 65 PANVAC VF 65 Daniel Junius 65 Cetuximab Erbitux 65 CYT# potent vascular disrupting 65 SUTENT ® 65 Telatinib 65 Novolimus 65 tremelimumab 65 epigenetic therapies 65 Tocosol Paclitaxel 65 ProLindac 65 Nanobody ® 65 Targeted Chemotherapy 65 Squalamine 65 thetreatment 65 renin inhibition 65 sorafenib Nexavar ® 65 mTOR inhibition 65 Triapine 65 Zenvia ™ 65 Dapagliflozin 65 phase IIb study 65 Proxinium TM 65 multi kinase inhibitor 65 molecular imaging radiopharmaceutical 65 Mepact 65 R#/MEM # 65 Selective Electrochemical Tumor Ablation 65 Enhanze Technology 65 JAK inhibitors 65 Ocrelizumab 65 Nexavar sorafenib 65 CD# CEA 65 Hematide ™ 65 candidate AQ4N 65 commercialize deforolimus 65 xanthine oxidase inhibitor 65 UPLYSO 65 ToGA 65 initiate Phase Ib 65 oral antiviral 65 DermaVir Patch 65 Phase #b/#a trial 65 tranilast 65 cytokine refractory 65 KRN# 65 Campath alemtuzumab 65 JAK1 65 StemEx R 65 rNAPc2 65 Nanobody R 65 ALN VSP Phase 65 Orazol 65 PRECISE Trial 65 evaluating mipomersen 65 GetGoal Phase III 65 Ozarelix 65 oxymorphone ER 65 ® natalizumab 65 clofarabine 65 Ketotransdel 65 Immunotherapeutic 65 ruxolitinib 65 OMNARIS Nasal Spray 65 HCD# [002] 65 R#/MEM 65 Hedgehog Pathway Inhibitor 65 investigational HCV polymerase 65 investigational therapies 65 Benlysta belimumab 65 MLN# 65 CINQUIL 65 multiple myeloma MM 65 Octreolin 65 BLA filing 65 predictive biomarkers 65 methylnaltrexone 65 SinuNase TM 65 elacytarabine 65 ARRY # 65 E2F Decoy 65 Gemzar ® 65 Targretin capsules 65 PDX pralatrexate 65 TRO# 65 Clonicel 65 MKC# MKC# PP 65 APPRAISE 65 hematological indications 65 Phase 2a 65 sorafenib tablets 65 HyACT 65 romazarit 65 immunotherapeutic agent 65 dexanabinol 65 cardio renal 65 Bexion 65 cilengitide 65 ATL# [002] 65 outlicensing 65 tesmilifene 65 selective S#P# receptor agonist 65 phase Ib 65 Fx #A 65 Phase Ib clinical trials 65 Locteron ® 65 histone deacetylase HDAC inhibitor 65 RH1 65 personalized immunotherapy 64 MAXY alpha 64 AKT inhibitor 64 ® bortezomib 64 LEVADEX ™ 64 NVA# 64 Lixivaptan 64 Phase 2a clinical 64 Rebif ® 64 Panzem NCD 64 trastuzumab DM1 64 AeroLEF TM 64 PARTNER Trial 64 Phase 2a clinical trials 64 HuMax CD4 64 eTag assays 64 Thalomid ® 64 ongoing Phase IIIb 64 Angiocept 64 EDEMA3 64 Lung Rx 64 subcutaneous formulation 64 GALNS 64 lenalidomide Revlimid 64 MDV# 64 Ereska 64 KYTHERA 64 pain palliation 64 synthetic retinoid 64 arzoxifene 64 fosbretabulin 64 RSD# oral 64 AAG geldanamycin analog 64 BEMA TM Fentanyl 64 LEP ETU 64 Zensana TM 64 Hsp# inhibition 64 novel anticancer 64 OvaRex 64 MAGE A3 ASCI 64 OncoVex 64 Plicera 64 TLK# 64 Oral NKTR 64 XL# XL# XL# XL# 64 OncoVEX GM CSF 64 LY# [003] 64 initiate Phase IIb 64 Imprime PGG ® 64 bosutinib 64 tecarfarin 64 RIGScan CR 64 HSP# inhibitor 64 velafermin belinostat 64 farletuzumab 64 Vivecon 64 gemcitabine Gemzar R 64 adipiplon 64 PORxin TM 64 AQ4N 64 Toraymyxin TM 64 lesinurad 64 Phase 2b 64 Prestara 64 Golimumab 64 IGF 1R inhibitor 64 INTEGRILIN 64 Phase IIa trial 64 Phase Ib IIa 64 IgG1 monoclonal antibody 64 RIGScan 64 pediatric acute lymphoblastic 64 ongoing Phase 1b 64 oxaliplatin Eloxatin 64 Hedgehog antagonist 64 EP #R 64 Factor Xa inhibitor 64 RhuDex TM 64 Daclizumab 64 Alocrest 64 ocular formulation 64 novel therapeutic antibodies 64 preclinical efficacy 64 VEGF Trap 64 Tesmilifene 64 Relovair 64 severe hypercholesterolemia 64 TASKi2 64 interferon gamma 1b 64 Firazyr 64 TKM ApoB 64 Beyond Advair 64 relapsed MM 64 clinical pharmacology studies 64 Phase 1a 64 novel VDA molecule 64 hoFH 64 Zemplar Capsules 64 HCV protease inhibitors 64 DPP4 inhibitor 64 tesetaxel 64 Spiegelmer ® 64 XP# XP# 64 cMET 64 NV1FGF 64 GVAX ® 64 Triapine R 64 sNDA submission 64 Actimmune ® 64 Zolinza 64 trial evaluating PRX# 64 rindopepimut 64 cancer neuroendocrine tumor 64 Traficet EN 64 Initiates Enrollment 64 HCV antiviral 64 TMC# [002] 64 XL# XL# 64 brentuximab vedotin 64 Cimzia TM 64 vismodegib 64 renin inhibitors 64 macitentan 64 tamibarotene 64 LymphoStat B 64 Solazed TM 64 MabThera rituximab 64 Zavesca r 64 Theratope 64 prostone 64 Phase III TRIST 64 SCH # 64 DCVax R 64 GLP toxicology studies 64 MEK inhibitor RDEA# 64 chemotherapy FOLFOX 64 CINTREDEKIN BESUDOTOX 64 DCCR 64 phase 2a 64 TRACON Pharmaceuticals 64 Cerimon 64 phase IIa 64 Zemiva TM 64 evaluating REVLIMID 64 Viprinex TM 64 lenalidomide Revlimid R 64 Elvitegravir 64 Completes Patient Enrollment 64 ProSavin 64 lymphoid malignancies 64 CTAP# Capsules 64 Sopherion 64 aflibercept 64 Phase 1b clinical 64 hematological cancers 64 advanced carcinoid 64 Urocidin TM 64 EDEMA3 trial 64 generation proteasome inhibitor 64 oral anticancer 64 glatiramer 64 eritoran 64 rALLy trial 64 initiate Phase 2b 64 Temsirolimus 64 Cloretazine R 64 lapatinib Tykerb 64 RezularTM 64 MyVax R 64 TTF Therapy 64 teriflunomide 64 xenograft models 64 inhibit metastasis 64 OncoGel 64 SAR# [002] 64 OMNARIS HFA 64 Phase IIB 64 Anacetrapib 64 bortezomib Velcade 64 HuMax CD# 64 refractory chronic lymphocytic 64 sodium thiosulfate STS 64 immune modulating 64 elinogrel 64 PARP inhibitor 64 NXL# 64 maximally tolerated dose 64 Pazopanib 64 Canvaxin 64 PD LID 64 ZEVALIN ® 64 Tracleer r 64 PNT# 64 TREANDA 64 belinostat 64 CCX# 64 class mGluR5 inhibitor 64 ProLindac TM 64 edoxaban 64 dextromethorphan quinidine 64 Saforis 64 Bayer HealthCare Onyx Pharmaceuticals 64 generation purine nucleoside 64 Cethrin 64 pemetrexed Alimta 64 TOLAMBA 64 AVASTIN 64 Pralatrexate 63 Initiates Phase II 63 Q#IR 63 multitargeted 63 nilotinib Tasigna 63 adecatumumab 63 RLY# 63 TRISENOX 63 evaluating picoplatin 63 omega interferon 63 varespladib 63 DXL# 63 triphendiol 63 GENASIS 63 evaluating Actimmune 63 vascular disrupting agent 63 APEX PD 63 nonclinical studies 63 ZACTIMA 63 P#X# antagonist 63 SILENOR 63 delafloxacin 63 Xerecept 63 midstage studies 63 catheter occlusion 63 Exelixis XL# 63 induced macular edema 63 proteasome inhibitor 63 confirmatory pivotal 63 metastatic hormone refractory 63 Thiovir 63 AVOREN 63 Gemin X 63 Phase 1b clinical trials 63 Sudhir Agrawal D.Phil 63 Phase 2b clinical 63 Elagolix 63 Lenocta 63 orally bioavailable 63 ostarine 63 Uvidem 63 PRX # 63 RNAi therapeutic targeting 63 apaziquone 63 HuCAL antibodies 63 PhosLo 63 kidney urologic 63 lasofoxifene 63 Smac mimetics 63 Vidaza azacitidine 63 Virulizin ® 63 Hsp# Inhibitor 63 brivanib 63 pregabalin Lyrica 63 CINOD 63 NEBIDO 63 immunotherapeutic vaccine 63 HuMax 63 Muraglitazar 63 GED aPC 63 Nicole Onetto MD 63 orBec 63 IMiD 63 daclizumab 63 Achieves Primary Endpoint 63 HCV polymerase inhibitors 63 panitumumab Vectibix 63 IPL# 63 XYOTAX TM 63 ASA# 63 Vicriviroc 63 MoxDuo IR 63 pazopanib 63 brivaracetam 63 intranasal formulation 63 exemestane Aromasin 63 novel peptide 63 immuno therapeutic 63 oncolytic virus therapies 63 IMiDs ® 63 Phase III confirmatory 63 Hepatocellular Carcinoma HCC 63 XL# anticancer compounds 63 WILEX 63 KNS # 63 plasma kallikrein inhibitor 63 OZURDEX ® 63 UltiMAb 63 Onalta ™ 63 TOCOSOL Camptothecin 63 oral Azacitidine 63 cobiprostone 63 goserelin 63 ADVANCE PD 63 faropenem 63 CIMZIA TM 63 Vaxfectin TM 63 telaprevir VX 63 zileuton CR 63 Guanilib 63 GAP #B# 63 acetonide FA 63 Intravenous CP 63 Shigamabs ® 63 Phase 2b trial 63 mitogen activated ERK kinase 63 Phase IIb clinical 63 Androxal TM 63 ZFP Therapeutics 63 ONCONASE 63 Technosphere Insulin 63 Vascugel 63 baminercept 63 systemically administered 63 p# inhibitor 63 Copegus ribavirin 63 Zalypsis 63 Neulasta ® 63 Oncogenex 63 MKC# MT 63 Kamada AAT 63 Vaxfectin R 63 candidate TNFerade biologic 63 Zerenex ™ 63 Stimuvax R 63 rasagiline tablets 63 Zosano 63 GRNVAC1 63 BCIRG 63 investigational immunotherapy 63 kinase inhibitor 63 Xcellerated T Cells 63 Intarcia 63 ganaxolone 63 standard chemotherapy regimen 63 2 methoxyestradiol 63 Harry Palmin President 63 Adrian Hobden Ph.D. 63 riociguat 63 SCIB1 63 BENLYSTA TM 63 Simulect 63 assessing T DM1 63 Provecta 63 tiapamil 63 IND submission 63 HDL Mimetic Peptide 63 IV APAP 63 paclitaxel poliglumex 63 Romidepsin 63 TAFA# 63 Genasense ® 63 Angiolix 63 dirucotide MBP# 63 Cand5 63 Unit Dose Budesonide 63 Pharmion Corporation 63 Æterna Zentaris 63 miconazole Lauriad ® 63 PSN# [001] 63 Vidaza R 63 albiglutide 63 metastatic CRC 63 radezolid 63 Allovectin 7 r 63 Treanda 63 REOLYSIN ® 63 PREOS R 63 XL# XL# XL# 63 Litx 63 ADP receptor antagonist 63 dirucotide 63 bortezomib Velcade R 63 budiodarone 63 Surfaxin LS 63 Pervasis 63 TYSABRI natalizumab 63 investigational monoclonal antibody 63 Varespladib 63 iniparib 63 Chrysalin 63 drug conjugate 63 ISIS # 63 PRIMO CABG 63 Neuvenge 63 PORxin TM platforms 63 inhaled formulation 63 PROSTVAC TM 63 Zymafos 63 PrevOnco 63 Tesetaxel 63 EGS# 63 demonstrated antitumor activity 63 drug GAP #B# 63 successfully commercialize Iluvien 63 EnzymeRx 63 BioNumerik 63 Celator 63 MK #B 63 dalbavancin 63 visilizumab 63 Rigel R# 63 Aganocide 63 peginesatide 63 epothilones 63 adalimumab Humira 63 ThermoDox ® clinical 63 adecatumumab MT# 63 Marqibo 63 oral rivaroxaban 63 preclinical pharmacokinetic 63 sorafenib Nexavar R 63 oral dnaJP1 63 investigational compound 63 Begins Dosing 63 LEVADEX 63 Azedra ™ 63 IAP inhibitor 63 Amigal 63 ORENCIA R 63 Novosom 63 Desmoteplase 63 Panitumumab 63 Cx# [002] 63 vaccines oncolytic virus 63 Alzhemed TM 63 ZD# [001] 63 targeted antifolate 63 Veronate 63 Sphingomab 63 danoprevir 63 candidate CRLX# 63 IMiDs R 63 nab paclitaxel 63 antisense inhibitors 63 SonoLysis 63 Blinatumomab 63 GFT# 63 TroVax 63 Folotyn 63 paclitaxel Taxol 63 cystinosis patients 63 sargramostim 63 perifosine 63 Zerenex 63 Onrigin 63 INT# [002] 63 Phase 2b Clinical Trial 63 TKB# 62 Modrenal R 62 PA# [002] 62 palifosfamide 62 gemcitabine Gemzar 62 Davanat 62 budesonide foam 62 randomized Phase 2b 62 NASDAQ FLML 62 taribavirin 62 darapladib 62 Cinquil 62 ONCASPAR 62 Aloxi injection 62 histone deacetylase inhibitor 62 Ophthotech 62 NSABP C 62 staphylococcal vaccine 62 LE DT 62 Tezampanel 62 outlicensed 62 ALN TTR# 62 NSABP 62 Numoda 62 indolent NHL 62 selective androgen receptor modulators 62 torsemide ER 62 mapatumumab 62 REG1 62 Inhalation Solution 62 Glufosfamide 62 mGluR2 NAM

Back to home page